Paper17545512
The mammalian target of rapamycin signaling pathway: twists and turns in the road to cancer therapy.
Abraham RT and 1 other. Clin Cancer Res, 2007. Cited by 203 papers, by iCite.
Cite this record
ConductScience Library. The mammalian target of rapamycin signaling pathway: twists and turns in the road to cancer therapy. Papers, record 17545512. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17545512
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The mammalian target of rapamycin signaling pathway: twists and turns in the road to cancer therapy.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gene Expression Regulation, Neoplastic | Major topic |
| Neoplasms | Major topic |
| Protein Kinases | Major topic |
| Signal Transduction | Major topic |
| Animals | |
| Antineoplastic Agents | |
| Cell Enlargement | |
| Cell Proliferation | |
| Genes, Fungal | |
| Genotype | |
| Humans | |
| Models, Biological | |
| Phosphorylation | |
| TOR Serine-Threonine Kinases |
Source PubMed
Cited by92
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 203 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40692147 | Machine Learning, Virtual Screening and Bioactivity Evaluation to Identify AJ-292/12941271 as an Anti-proliferative Agent and Target mTOR Protein. | Curr Med Chem | 2026 | https://conductscience.org/library/papers/40692147 | PubMed |
| 39178846 | mTORC1 mediates the expansion of hematopoietic stem and progenitor cells through ribosome biogenesis protein Urb2 in zebrafish. | Stem Cell Reports | 2024 | https://conductscience.org/library/papers/39178846 | PubMed |
| 37730584 | Formulation of cost-effective medium and optimization studies for enhanced production of rapamycin. | Microb Cell Fact | 2023 | https://conductscience.org/library/papers/37730584 | PubMed |
| 36062877 | Role of mechanistic target of rapamycin in autophagy and alcohol-associated liver disease. | Am J Physiol Cell Physiol | 2022 | https://conductscience.org/library/papers/36062877 | PubMed |
| 35592432 | Rapamycin in Cerebral Cavernous Malformations: What Doses to Test in Mice and Humans. | ACS Pharmacol Transl Sci | 2022 | https://conductscience.org/library/papers/35592432 | PubMed |
| 35530150 | c-MYC-mediated TRIB3/P62+ aggresomes accumulation triggers paraptosis upon the combination of everolimus and ginsenoside Rh2. | Acta Pharm Sin B | 2022 | https://conductscience.org/library/papers/35530150 | PubMed |
| 34769263 | Effect of Epigallocatechin-3-Gallate on EGFR Signaling and Migration in Non-Small Cell Lung Cancer. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34769263 | PubMed |
| 33801030 | Marine-Derived Natural Products as ATP-Competitive mTOR Kinase Inhibitors for Cancer Therapeutics. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/33801030 | PubMed |
| 33638305 | A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies. | Cancer Med | 2021 | https://conductscience.org/library/papers/33638305 | PubMed |
| 33165737 | mTOR-targeted cancer therapy: great target but disappointing clinical outcomes, why? | Front Med | 2021 | https://conductscience.org/library/papers/33165737 | PubMed |
| 33053934 | Autophagy and liver cancer. | Clin Mol Hepatol | 2020 | https://conductscience.org/library/papers/33053934 | PubMed |
| 31856761 | Direct physical interaction of active Ras with mSIN1 regulates mTORC2 signaling. | BMC Cancer | 2019 | https://conductscience.org/library/papers/31856761 | PubMed |
| 31464606 | ALI multilayered co-cultures mimic biochemical mechanisms of the cancer cell-fibroblast cross-talk involved in NSCLC MultiDrug Resistance. | BMC Cancer | 2019 | https://conductscience.org/library/papers/31464606 | PubMed |
| 31316145 | Inhibition of mTOR complex 1/p70 S6 kinase signaling elevates PD-L1 levels in human cancer cells through enhancing protein stabilization accompanied with enhanced β-TrCP degradation. | Oncogene | 2019 | https://conductscience.org/library/papers/31316145 | PubMed |
| 31095752 | Dual Roles of Mammalian Target of Rapamycin in Regulating Liver Injury and Tumorigenesis in Autophagy-Defective Mouse Liver. | Hepatology | 2019 | https://conductscience.org/library/papers/31095752 | PubMed |
| 30664178 | Identification of key genes and pathways involved in microsatellite instability in colorectal cancer. | Mol Med Rep | 2019 | https://conductscience.org/library/papers/30664178 | PubMed |
| 30513765 | Current Landscape and the Potential Role of Hypoxia-Inducible Factors and Selenium in Clear Cell Renal Cell Carcinoma Treatment. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/30513765 | PubMed |
| 30050079 | Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells. | Cell Death Dis | 2018 | https://conductscience.org/library/papers/30050079 | PubMed |
| 29702026 | Dietary polyphenols promote resilience against sleep deprivation-induced cognitive impairment by activating protein translation. | FASEB J | 2018 | https://conductscience.org/library/papers/29702026 | PubMed |
| 29165391 | MicroRNAs Associated with Von Hippel-Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/29165391 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MTOR | 2475 | PubTator's text mining | https://conductscience.org/library/genes/2475 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17545512
GET https://conductscience.org/api/papers/v1/17545512/cited_by?page=2